Genentech
Genentech, Inc. is one of the world's most financially successful biotechnology corporations. Genentech, which is based in San Francisco, California, U.S., is 56% owned by Swiss drug company Roche. [1]
Contents
Lobbying
According to Lisa Graves of the Center for Media and Democracy a search of the Lobby Disclosure Act database for "Genentech" spending in 2009 reveals that the company spent over $3.7 million in lobbying Congress on health care issues in the first three quarters on the year, including over $2.1 million itself and the remainder on lobbyists such as the American Continental Group.[2] Genentech's lobbying made the news after its talking points showed up in the statements that several Members of Congress submitted to the Congressional Record, the official journal of congressional proceedings, during the 2009 debate over health care reforms.[3]
Political contributions
Genentech gave almost $400,000 to candidates in the 2008 election cycle through its political action committee.[4] This is almost twice as much as in 2006, when it donated $201,500 to federal candidates in the 2006 election through its political action committee - 38% to Democrats and 57% to Republicans.Cite error: Closing </ref> missing for <ref> tag
- Susan D. Desmond-Hellmann, Divisional President, $7,820,142 (also exercised $33,465,041 in options)[5]
- David A. Ebersman, Chief Financial Officer, $4,030,747[6]
- Stephen G. Juelsgaard, Executive Vice President, $4,896,340 (also exercised $24,980,534 in options)[7]
- Richard H. Scheller, Divisional Executive Vice President, $4,992,779 (also exercised $10,880,395 in options)[8]
Selected staff
- Laura A. Leber
- J. Richard Munro - Retired Chairman of the Board [9]
- William D. Young - Former Chief Operating Officer [10]
- Amo Houghton
Products
The company has three drugs that are billion-dollar sellers: Rituxan, for non-Hodgkin's lymphoma; Avastin, for colorectal and non-small cell lung cancers, which also treats macular degeneration; and Herceptin for breast cancer. It also has the lung cancer drug Tarceva. Big customers for its drugs are AmerisourceBergen, Cardinal Health, and McKesson.
In 2006, Genentech sales were US$9.3 billion with profits of US$2.1 billion. [1]
Animal testing
Genentech does animal testing.
Animals by species, numbers & location
- Genentech, Inc., San Francisco, California [11]
For links to copies of this facility's U.S. Department of Agriculture reports indicating species, number of animals used and other information visit Stop Animal Experimentation Now Facility Reports and Information, U.S. Department of Agriculture-Animal Plant Health Inspection reports. This Web site lists each of the 50 states; each state's name links to biomedical research facilities in that state, and to PDF copies of government documents where the facilities must report their animal usage.
From its website
"Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needs." [12]
Board of Directors
- Herbert W. Boyer, Ph.D., Also Vice-Chairman of the Board of Directors of Allergan, Inc.
- William M. Burns
- Erich Hunziker
- Jonathan K.C. Knowles, Ph.D.
- Arthur D. Levinson, Ph.D., Also member of the Board of Directors of Apple Computer, Inc.
- Debra L. Reed, Also on the Board of Directors of Halliburton Company
- Charles A. Sanders, M.D.
Contact details
1 DNA Way
South San Francisco, CA 94080
Phone: 650-225-1000
Fax: 650-225-6000
Web: http://www.gene.com
Articles & sources
Sourcewatch articles
References
- ↑ Jump up to: 1.0 1.1 Genentech Profile, Hoovers, accessed December 2007.
- ↑ Lisa Graves, Center for Media and Democracy, "Biotech's Ghostwriting Animates Congressional Speeches on Health Reform, November 15, 2009.
- ↑ Robert Pear, New York Times, "In House, Many Spoke with One Voice: Lobbyists," November 15, 2009, [1].
- ↑ [2], "CampaignMoney.com," accessed on November 15, 2009.
- ↑ Susan D Desmond-Hellmann, Forbes, accessed December 2007.
- ↑ David A Ebersman, Forbes, accessed December 2007.
- ↑ Stephen G Juelsgaard, Forbes, accessed December 2007.
- ↑ Richard H Scheller, Forbes, accessed December 2007
- ↑ Points of Light Foundation, Board of Directors, accessed July 2007
- ↑ BiogenIDECBoard of Directors, , accessed July 2007
- ↑ Humane Society of the U.S. Genentech, Inc., San Francisco, California, Research Facilities, accessed May 2009
- ↑ Corporate Overview, Genentech, accessed July 27, 2007.
- ↑ Genentech, Inc. Board of Directors, accessed July 2007
